February 20, 2017 - February 21, 2017
USP is organizing a two-day workshop which will promote the exchange of information on the quality assessment of biopharmaceuticals and its implications on public health. This workshop will address the current challenges surrounding one of the fastest growing classes of drugs. Meant to encourage discussion and debate, the workshop will examine issues related to analytical characterization, product-related substances, impurities and regulatory considerations of therapeutic peptides and biotherapeutics both from compendial and industry perspectives. An update on the development and modernization of relevant USP biologic standards will be presented along with case studies. Attend lively panel discussions with regulators and experts across the industry.
Speakers will include representatives from the US FDA, EDQM, National Research Council Canada, USP Expert Committee members and subject matter experts from USP, and key personnel from the Indian Pharma Industry.
- Plenary Session
- Analytical Characterization
- Advances in Technology
Who Should Participate?
- Representatives from biopharma areas such as, quality control, quality assurance, research and development
- Regulatory and compendial liaisons
- Manufacturers, exporters and importers of medicines and their ingredients
- Policy makers
Download the registration PDF by selecting the blue "Register" button. Once completed, send form and payment information to AS@usp.org.
Marigold by Greenpark
Hyderabad - 500 016.
P: +91 40 6736 3636
F: +91 40 6736 3637